Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line-Reference-Cited by-同舟云学术

Tobramycin and Colistin display anti-inflammatory properties in CuFi-1 cystic fibrosis cell line

Published:2021-07 Issue: Volume:902 Page:174098
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Sheikh Zara,Bradbury Peta,Reekie Tristan A.,Pozzoli Michele^ORCID,Robinson Paul D.^ORCID,Kassiou Michael^ORCID,Young Paul M.,Ong Hui Xin^ORCID,Traini Daniela

Funder

Cystic Fibrosis in Australia

Publisher

Elsevier BV

Subject

Pharmacology

Reference39 articles.

1. Emerging drugs for cystic fibrosis;Amin;Expet Opin. Emerg. Drugs,2014

2. Some aspects of the NMR chemical shift/structure correlation in the structural characterization of polymers and biopolymers;Ando;Polym. J.,2012

3. Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa;Bergen;Antimicrob. Agents Chemother.,2006

4. Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modeling;Bulitta;Antimicrob. Agents Chemother.,2015

5. New inhaled antimicrobial formulations for use in the cystic fibrosis patient population;Campbell;Ann. Pharmacother.,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual functional therapeutics: mitigating bacterial infection and associated inflammation;RSC Medicinal Chemistry;2023

2. Development of excipients free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two and three fluid nozzles;International Journal of Pharmaceutics;2022-08